tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Century Therapeutics Launches Type 1 Diabetes Program
PremiumCompany AnnouncementsCentury Therapeutics Launches Type 1 Diabetes Program
1M ago
Century Therapeutics reports Q3 EPS (40c) vs (37c) last year
Premium
The Fly
Century Therapeutics reports Q3 EPS (40c) vs (37c) last year
1M ago
Century Therapeutics announces new beta islet program for Type 1 diabetes
Premium
The Fly
Century Therapeutics announces new beta islet program for Type 1 diabetes
1M ago
Century Therapeutics: Strategic Workforce Reduction and Financial Position Justify Hold Rating Amid Developmental Progress and Challenges
PremiumRatingsCentury Therapeutics: Strategic Workforce Reduction and Financial Position Justify Hold Rating Amid Developmental Progress and Challenges
4M ago
Century Therapeutics Reports Q2 Results and Leadership Change
Premium
Company Announcements
Century Therapeutics Reports Q2 Results and Leadership Change
4M ago
Century Therapeutics files $200M mixed securities shelf
Premium
The Fly
Century Therapeutics files $200M mixed securities shelf
6M ago
Century Therapeutics: Strategic Advancements and Promising Preclinical Data Justify Buy Rating
PremiumRatingsCentury Therapeutics: Strategic Advancements and Promising Preclinical Data Justify Buy Rating
8M ago
Century Therapeutics price target lowered to $2 from $5 at H.C. Wainwright
Premium
The Fly
Century Therapeutics price target lowered to $2 from $5 at H.C. Wainwright
9M ago
Century Therapeutics price target lowered to $7 from $11 at Chardan
Premium
The Fly
Century Therapeutics price target lowered to $7 from $11 at Chardan
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100